— Know what they know.
Not Investment Advice

EBAY vs AZO vs SE

161 measures in 16 categories, one definition each, computed from filings and market data.
EBAY70.6
eBay Inc.
Consumer Cyclical · Specialty Retail
$120.28 −2.14%$53.5B mkt cap
Score DNA
AZO50.8
AutoZone, Inc.
Consumer Cyclical · Specialty Retail
$3,120.59 +2.03%$50.9B mkt cap
Score DNA
SE65.8
Sea Limited
Consumer Cyclical · Specialty Retail
$93.77 −3.86%$57.4B mkt cap
Score DNA

Price, rebased to 100 three years ago

EBAY   AZO   SE   · weekly adjusted closes
100150200250300350400450Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26EBAY 303SE 206AZO 122
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures
MeasureEBAYAZOSE
Insider open-market buys, 180d 0 1 0
Insider $ bought, 180d — $0.49M —
Congress purchases, 180d 0 4 0
Last Congress purchase — 2026-09-25 —
13F net change in holders +51 −22 +29
ETFs adding shares, 30d 1,114 998 443
ETFs trimming, 30d 1,260 936 338
Net ETF funds, 30d −146 +62 +105

Valuation

16 measures
MeasureEBAYAZOSE
P/E (TTM) 24.1x
54th
19.8x
31st
35.1x
77th
PEG (P/E ÷ 3-yr EPS CAGR) 0.97
42nd
5.02
89th
0.46
16th
Price / sales 4.5x
95th
2.5x
72nd
2.1x
67th
Price / book 11.5x
81st
— 4.4x
47th
Price / tangible book 263.2x
96th
— 4.9x
37th
Price / free cash flow 22.0x
58th
32.5x
75th
18.5x
42nd
Price / operating cash flow 18.0x
76th
17.6x
70th
11.0x
43rd
Enterprise value $57.3B
90th
$63.1B
92nd
$52.5B
87th
EV / sales 4.8x
95th
3.1x
77th
1.9x
64th
EV / EBITDA 18.9x
73rd
15.1x
59th
18.3x
70th
EV / EBIT 21.0x
66th
16.9x
43rd
21.4x
69th
EV / free cash flow 23.6x
53rd
40.2x
72nd
16.9x
33rd
Earnings yield 4.2%
51st
5.1%
72nd
2.9%
31st
FCF yield 4.5%
46th
3.1%
31st
5.4%
62nd
Operating cash flow yield 5.6%
28th
5.7%
33rd
9.1%
59th
Graham number (per share) $33.42
60th
— $33.33
57th

Profitability (TTM)

12 measures
MeasureEBAYAZOSE
Gross margin 72.5%
97th
52.3%
77th
44.3%
56th
EBITDA margin 25.3%
92nd
20.6%
85th
10.3%
49th
Operating margin 20.5%
97th
18.3%
90th
8.0%
49th
EBIT margin 22.7%
92nd
18.3%
85th
8.8%
54th
Net margin 18.5%
95th
12.6%
82nd
5.9%
56th
NOPAT margin 18.1%
97th
14.5%
92nd
5.3%
49th
FCF margin 20.2%
90th
7.7%
62nd
11.2%
72nd
Operating cash flow margin 24.7%
92nd
14.3%
67th
18.8%
77th
R&D / revenue 14.9%
95th
0.0%
0th
4.2%
85th
SG&A / revenue 32.7%
69th
34.0%
74th
30.9%
59th
Stock comp / revenue 4.0%
92nd
0.6%
43rd
1.6%
68th
Effective tax rate 11.8%
5th
20.9%
29th
33.2%
97th

Returns on capital

11 measures
MeasureEBAYAZOSE
ROE (on average equity) 47.2%
88th
— 14.5%
34th
ROA 12.4%
72nd
12.6%
77th
5.7%
38th
ROIC 25.6%
74th
30.6%
79th
18.6%
62nd
ROCE 22.7%
72nd
32.3%
85th
15.4%
49th
Return on tangible assets 15.2%
69th
18.2%
74th
8.5%
41st
Cash ROIC (OCF / invested capital) 35.0%
67th
30.1%
61st
65.7%
86th
Gross profitability (GP / assets) 48.5%
49th
49.2%
54th
38.4%
28th
ROIC, 3-yr average 22.8%
75th
40.2%
88th
—
ROIC, 5-yr average 17.9%
62nd
— 36.6%
83rd
ROE, 5-yr average 34.9%
73rd
— -4.7%
23rd
Incremental ROIC -212.9%
0th
90.6%
79th
21.0%
45th

Growth

17 measures
MeasureEBAYAZOSE
Revenue growth (TTM YoY) 14.7%
74th
7.4%
41st
43.1%
92nd
Revenue growth (QoQ) 1.5%
28th
36.2%
95th
9.7%
59th
Revenue CAGR, 3 yr 6.5%
54th
5.2%
49th
29.6%
90th
Revenue CAGR, 5 yr 2.9%
31st
6.8%
46th
32.4%
89th
Gross profit CAGR, 3 yr 6.6%
54th
5.5%
46th
28.5%
90th
Operating income CAGR, 3 yr 3.7%
50th
2.3%
40th
104.9%
97th
Net income growth (TTM YoY) 1.7%
34th
3.0%
38th
35.6%
76th
Net income CAGR, 3 yr 18.3%
70th
0.6%
40th
80.9%
93rd
EPS growth (TTM YoY) 4.6%
34th
4.9%
41st
22.7%
62nd
EPS CAGR, 3 yr 24.9%
80th
3.9%
43rd
75.6%
93rd
EPS CAGR, 5 yr -23.7%
8th
9.1%
71st
—
FCF growth (TTM YoY) 72.4%
78th
-12.3%
31st
-24.5%
22nd
FCF CAGR, 3 yr 1.0%
35th
-9.9%
13th
118.7%
97th
Operating cash flow CAGR, 3 yr 1.3%
29th
-0.5%
26th
56.7%
91st
Book value CAGR, 3 yr 1.3%
20th
— 22.0%
73rd
Dividend CAGR, 3 yr 6.4%
54th
— —
Sustainable growth rate 35.7%
83rd
— 14.5%
37th

Margin history & stability

7 measures
MeasureEBAYAZOSE
Gross margin, 3-yr average 72.1%
97th
52.7%
77th
43.8%
51st
Operating margin, 3-yr average 20.7%
97th
19.3%
92nd
5.1%
41st
Net margin, 3-yr average 21.9%
97th
13.4%
90th
3.6%
44th
FCF margin, 3-yr average 16.2%
90th
9.2%
72nd
15.0%
85th
Revenue stability (0-1) 0.38
21st
0.98
90th
0.92
62nd
Earnings stability (0-1) 0.29
33rd
0.55
59th
0.80
87th
Margin stability (0-1) 0.98
74th
0.99
97th
0.92
28th

Liquidity (latest quarter)

7 measures
MeasureEBAYAZOSE
Cash & short-term investments $3.3B
87th
$326.1M
56th
$9.1B
97th
Net cash (− = net debt) −$3.8B
21st
−$12.1B
3rd
$5.0B
100th
Working capital $111.0M
38th
−$1.0B
5th
$8.0B
97th
Current ratio 1.02
28th
0.90
18th
1.49
62nd
Quick ratio 1.02
67th
0.14
3rd
1.48
79th
Cash ratio (cash + ST investments / current liabilities) 0.56
67th
0.03
8th
0.57
69th
Defensive interval (days) 315 days
77th
17 days
0th
684 days
95th

Leverage & solvency (latest quarter)

13 measures
MeasureEBAYAZOSE
Total debt $7.1B
87th
$12.4B
95th
$4.1B
69th
Debt / equity 1.53
66th
— 0.32
12th
Net debt / equity 0.82
53rd
— −0.39
12th
Debt / assets 39.8%
56th
57.5%
82nd
12.9%
10th
Debt / capital 60.4%
66th
— 24.2%
12th
Debt / EBITDA 2.35
41st
2.97
49th
1.44
22nd
Net debt / EBITDA 1.26
38th
2.89
65th
−1.74
11th
Interest coverage (EBIT / interest) 11.0x
52nd
7.9x
45th
132.7x
94th
Cash interest coverage 11.9x
47th
6.1x
34th
282.3x
97th
Debt payback (years of OCF) 2.4 yrs
38th
4.3 yrs
68th
0.8 yrs
11th
Liabilities / assets 74.0%
54th
111.6%
90th
59.2%
31st
IS credit model rating AA- BBB- AA
Implied credit spread (bps) 100
23rd
350
62nd
80
18th

Efficiency

11 measures
MeasureEBAYAZOSE
Asset turnover 0.67
5th
0.99
28th
0.97
26th
Fixed asset turnover 7.08
66th
1.76
13th
8.10
68th
Inventory turnover — 1.3
3rd
69.7
97th
Receivables turnover 9.6
3rd
60.7
61st
77.9
75th
Days sales outstanding 38 days
97th
6 days
44th
5 days
31st
Days inventory outstanding — 278 days
97th
5 days
3rd
Days payables outstanding 38 days
31st
313 days
100th
10 days
3rd
Cash conversion cycle (days) −0 days
38th
−29 days
23rd
0 days
41st
Capex / revenue 4.5%
72nd
6.5%
85th
7.6%
92nd
Capex / depreciation 1.77
74th
2.86
95th
5.16
100th
Operating expense ratio 51.9%
87th
33.4%
56th
37.5%
69th

Cash flow & earnings quality

7 measures
MeasureEBAYAZOSE
Operating cash flow / net income 1.34
31st
1.13
9th
3.18
74th
FCF / net income 1.09
51st
0.61
20th
1.90
69th
FCF / operating cash flow 81.8%
78th
54.1%
32nd
59.6%
43rd
Capex / operating cash flow 18.3%
22nd
45.9%
68th
40.4%
57th
Accruals ratio -4.2%
62nd
-1.6%
92nd
-12.5%
18th
Sloan accruals ratio -1.0%
77th
-1.4%
72nd
1.9%
87th
Earnings quality score (0-1) 1.00
63rd
1.00
63rd
0.75
6th

Dividends & buybacks

9 measures
MeasureEBAYAZOSE
Dividend yield 1.0%
72nd
0.0%
0th
0.0%
0th
Dividend per share (TTM) $1.22
85th
$0.00
0th
$0.00
0th
Payout ratio (dividends / net income) 24.3%
77th
0.0%
0th
0.0%
0th
Dividends / FCF 22.2%
75th
0.0%
0th
0.0%
0th
Dividend growth (YoY) 5.4%
42nd
— —
Buyback yield 4.1%
77th
3.4%
69th
1.0%
46th
Shareholder yield (dividends + buybacks) 5.1%
74th
3.4%
54th
1.0%
36th
Share count change (YoY) -2.8%
26th
-1.8%
31st
10.5%
97th
Buybacks, last 5 years $6.8B
97th
$6.8B
95th
$742.0M
64th

Scores & forensic checks

15 measures
MeasureEBAYAZOSE
IS score 71
90th
51
38th
66
82nd
IS profitability 79
95th
52
69th
40
41st
IS growth 56
46th
58
54th
77
90th
IS value 42
54th
41
49th
33
26th
IS momentum 80
54th
72
31st
100
95th
IS risk (safety) 100
62nd
65
33rd
80
54th
IS quality 82
92nd
68
62nd
73
74th
IS balance sheet 63
62nd
36
18th
86
87th
IS earnings quality 74
28th
93
95th
50
8th
IS cash flow 75
85th
41
33rd
54
46th
Piotroski F-score (0-9) 9
97th
8
82nd
6
23rd
Altman Z-score 6.6
85th
2.7
36th
3.2
54th
Beneish M-score −2.14
79th
−3.34
10th
−2.48
69th
Ohlson O-score −7.11
44th
−6.36
67th
−8.60
13th
IS credit score 84
77th
51
36th
87
82nd

Per share

7 measures
MeasureEBAYAZOSE
EPS, diluted (TTM) $4.86
67th
$152.55
100th
$2.50
56th
Book value per share $10.21
59th
−$148.38
0th
$19.73
74th
Tangible book per share $0.43
31st
−$151.84
0th
$21.13
85th
Revenue per share $26.28
41st
$1,205.96
100th
$42.36
56th
FCF per share $5.32
72nd
$93.07
97th
$4.75
62nd
Operating cash flow per share $6.50
62nd
$171.89
97th
$7.97
64th
Cash per share $7.24
59th
$19.34
92nd
$13.90
90th

Size (TTM)

8 measures
MeasureEBAYAZOSE
Market cap $53.5B
90th
$50.9B
87th
$57.4B
92nd
Revenue $12.0B
64th
$20.3B
82nd
$27.7B
90th
EBITDA $3.0B
90th
$4.2B
97th
$2.9B
87th
Net income $2.2B
92nd
$2.6B
95th
$1.6B
87th
Free cash flow $2.4B
95th
$1.6B
87th
$3.1B
97th
Total assets $17.9B
87th
$21.6B
92nd
$32.0B
95th
Shareholders' equity $4.7B
87th
−$2.5B
3rd
$12.9B
97th
Employees 12,300
44th
130,000
97th
102,700
87th

Price performance

9 measures
MeasureEBAYAZOSE
1 day −2.1% +2.0% −3.9%
1 week +7.2% +6.2% −1.6%
1 month +6.5% +9.8% −7.4%
3 months +5.7% +4.3% −11.3%
6 months +15.6% −12.6% +2.6%
Year to date +39.4% −5.5% −28.7%
1 year +34.1% −22.5% −42.6%
3 years, cumulative +193.7% +21.4% +111.2%
5 years, cumulative +75.0% +85.7% −71.0%

Technicals

4 measures
MeasureEBAYAZOSE
RSI 14 70.0 66.9 36.1
From 52-week high −3.5% −22.9% −46.7%
From 52-week low +55.6% +14.3% +21.7%
Beta 1.32 0.34 1.55
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms